Early research (Phase 1)Ended earlyNCT03904251
What this trial is testing
CPX-351 and Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid Leukemia
Who this might be right for
Acute Myelogenous Leukemia
Jonsson Comprehensive Cancer Center 13